Form 4: BioLife Solutions EVP Aby J. Mathew Sells Shares to Cover Tax Obligations

Aby J. Mathew, EVP & Chief Scientific Officer of BioLife Solutions Inc., sold 92 shares of common stock on February 12, 2025, to satisfy tax withholding obligations related to vesting restricted stock.

Summary

• On February 12, 2025, Aby J. Mathew, the EVP & Chief Scientific Officer of BioLife Solutions Inc. (BLFS), sold 92 shares of common stock.
• The sale was executed at a price of $26.54 per share.
• The transaction was made pursuant to a Rule 10b5-1(c) trading plan adopted by Mathew on February 8, 2021.
• The purpose of the sale was to satisfy tax withholding obligations associated with the vesting of restricted stock.
• Following the transaction, Mathew directly owns 262,623 shares of BioLife Solutions Inc.

Sentiment

Score: 5

Explanation: The document describes a routine transaction (stock sale for tax purposes under a pre-existing 10b5-1 plan) and doesn't contain any information that would significantly impact investor sentiment positively or negatively.

Industry Context

This is a routine Form 4 filing related to an insider stock sale for tax purposes. It's common for executives to sell shares to cover tax obligations when restricted stock vests. The existence of a 10b5-1 plan suggests the sale was pre-planned and not based on current market information.

Key Dates

Keywords

Form 4, BioLife Solutions, BLFS, Aby J. Mathew, Stock Sale, Rule 10b5-1, Tax Obligations, Insider Trading